Page 19 - Read Online

Testa et al. J Cancer Metastasis Treat 2020;6:53 I http://dx.doi.org/10.20517/2394-4722.2020.111 Page 15 of 17

vessel proximity. Cell Metab 2019;30:1-11.
14. Chen J, Hendriks M, Chatzis A, Ramasamy SK, Kusumbe AP. Bone vasculature and bone marrow vascular niches in health and disease. J
Bone Min Res 2020;35:2103-20.
15. Kusumbe AP, Ramasamy SK, Adams RH. Coupling of angiogenesis and osteogenesis by a specific vessel subtype in bone. Nature
2014;507:323-8.
16. Spencer JA, Ferraro F, Roussakis E, et al. Direct measurement of local oxygen concentration in the bone marrow of live animals. Nature
2014;508:269-73.
17. Filipowska J, Tomaczewski KA, Niedzwiedzki L, Walocha JA, Niedzwedzki T. The role of vasculature in bone development, regeneration
and proper systemic functioning. Angiogenesis 2017;20:291-302.
18. Ramasamu SK, Kusumbe AP, Wang L, Adams RH. Endothelial Notch activity promotes angiogenesis and osteogenesis in bone. Nature
2014;507:376-80.
19. Ramasamy SK, Kusumbe AP, Schiller M, et al. Blood flow controls bone vascular function and osteogenesis. Nat Commun 2016;7:13601.
20. Xu CL, Gao X, Wei QZ, Nakahara F, et al. Stem cell factor is selectively secreted by arterial endothelial cells in bone marrow. Nat
Commun 2018;9:2449.
21. Ding L, Saunders TL, Enikolopov G, Morrison SJ. Endothelila and perivascular cells maintain hematopoietic stem eclls. Nature
2012;481:457-62.
22. Kenswil KJG, Jaramillo AC, Ping Z, et al. Characterization of endothelial cells associated with hematopoietic niche formation in humans
identifies IL-33 as an anabolic factor. Cell Rep 2018;22:666-78.
23. Himburg HA, Termini CM, Schlussel L, et al. Distinct bone marrow sources of pleiotrophin control hematopoietic stem cell maintenance
and regeneration. Cell Stem Cell 2018;23:370-81.
24. Chen Q, Liu Y, Jeong HW, et al. Apelin endothelial niche cells control hematopoiesis and mediate vascular regeneration after
+
myeloablative injury. Cell Stem Cell 2019,25:768-83.
25. Mokhtari S, Colletti E, Yin WH, et al. A human bone marrow mesodermal-derived cell population with hemogenic potential. Leukemia
2018;32:1575-86.
26. Mitroulis I, Chen LS, Singh RP, et al. Secreted protein Del-1 regulates myelopoiesis in the hematopoietic stem cell niche. J Clin Invest
2017;127:3624-39.
27. Passaro D, Di Tullio A, Abarrategi A, et al. Increased vascular permeability in the bone marrow microenvironment contributes to disease
progression and drug response in acute myeloid leukemia. Cancer Cell 2017;32:324-41.
28. Itkin T, Gur-Cohen S, Spencer JA, et al. Distinct bone marrow blood vessels differentially regulate hematopoiesis. Nature 2016;532:323-8.
29. Kusumbe AP, Ramasamy SK, Itkin T, et al. Age-dependent modulation of vascular niches for haematopoietic stem cells. Nature
2016;532:380-4.
30. Dar A, Goichberg P, Shinder V, et al. Chemokine receptor CXCR4-dependent internalization and resecretion of functional chemokine
SDF-1 by bone marrow endothelial and stromal cells. Nat Immunol 2005;6:1038-47.
31. Lévesque JP, Hendy J, Takamatsu Y, Simmons PJ, Bendall LJ. Disruption of the CXCR4/CXCL12 chemotactic interaction during
hematopoietic stem cell mobilization induced by GCSF or cyclophosphamide. J Clin Invest 2003;110:187-96.
32. Kim HK, Sierra M, Williams CK, Gulino AV, Tosato G. G-CSF down-regulation of CXCR4 expression identified as a mechanism for
mobilization of myeloid cells. Blood 2006;108:812-20.
33. Christopherson KW, Cooper S, Hangoc G, Broxmeyer HE. CD26 is essential for normal G-CSF-induced progenitor cell mobilization as
determined by CD26 mice. Exp Hematol 2003;31:1126-34.
-/-
34. Singh P, Hoggatt J, Kamocka M. et al. Neuropeptide Y regulates a vascular gateway for hematopoietic stem and progenitor cells. J Clin
Invest 2017;127:4527-40.
35. Boettcher S, Gerosa RC, Redpour R, et al. Endothelial cells translate pathogen signals into G-CSF-driven emergency gran ulopoiesis.
Blood 2014;124:1393-403.
36. Prendergast A, Kuck A, van Essen M, Haas S, Blaskiewicz S, Essers MAG. IFNa-mediated remodeling of endothelial cells in the bone
marrow niche. Haematologica 2017;102:445-53.
37. Duarte D, Hawkins ED, Akinduro O, et al. Inhibition of endosteal vascular niche remodeling rescues hematopoietic stem cell loss in
AML. Cell Stem Cell 2018;22:64-77.
38. Le PM, Andreef M, Battula VL. Ostogenic niche in the regulation of normal hematopoiesis and leukemogenesis. Haematologica
2018;103:1945-55.
39. Nilsson SK, Johnston HM, Whitty GA, et al. Osteopontin, a key component of the hematopoietic stem cell niche and regulator of
primitive hematopoietic progenitor cells. Blood 2005;106:1232-9.
40. Liersch R, Gerss J, Schliemann C, et al. Osteopontin is a prognostic factor for survival of acute myeloid leukemia patients. Blood
2012;119:5215-20.
41. Winkler IG, Barbier V, Nowlan B, et al. Vascular niche E-selectin regulates hematopoietic stem cell dormancy, self-renewal and
chemoresistance. Nat Med 2012;18:1651-61.
42. Spikins DA, Wei XB, Wei JW, et al. In vivo imaging of specialized bone marrow endothelial microdomains for tumour engraftment.
Nature 2005;435:969-73.
43. Ishikawa F, Yoshida S, Saito Y, et al. Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow
endosteal region. Nat Biotechnol 2007;25:1315-21.
44. Ninomiya M, Abe A, Katsumi A, et al. Homing, proliferation and survival sites of human leukemia cells in vivo in immunodeficient mice.